Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Delivering Nanoparticles to Cancer Cells 225

40. Zhao Y, Zhan Q. Electric oscillation and coupling of chromatin regulate
    chromosome packaging and transcription in eukaryotic cells. Theor. Biol.
    Med. Model. 9 , 27–38 (2012).


41. Hochwald SN. Molecular­targeted therapy for cancer and nanotech­
    nology. Methods Mol. Biol. 624 , 11–23 (2010).


42. Kanno S, Oda N, Abe M, Saito S, Hori K, Handa Y, Tabayashi K,
    Sato Y. Establishment of a simple and practical procedure applicable
    to therapeutic angiogenesis. Circulation 99 (20), 2682–2687
    (1999).


43. Mailänder V, Landfester K. Interaction of nanoparticles with cells.
    Biomacromolecules 10 , 2379–2400 (2009).


44. Biswas S, Torchilin VP. Nanopreparations for organelle­specific delivery
    in cancer. Adv. Drug Deliv. Rev. 66 , 26–41 (2014).


45. Pouponneau P, Leroux JC, Soulez G, Gaboury L, Martel S.
    Co­encapsulation of magnetic nanoparticles and doxorubicin into bio­
    degradable microcarriers for deep tissue targeting by vascular MRI navi­
    gation. Biomaterials 32 (13), 3481–3486 (2011).


46. Mannix RJ, Kumar S, Cassiola F, Montoya­Zavala M, Feinstein E,
    Prentiss M, Ingber DE. Nanomagnetic actuation of receptor­
    mediated signal transduction. Nat. Nanotechnol. 3 , 36–40 (2008).


47. Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic
    nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv.
    Rev. 62 , 284–304 (2010).


48. Lammers T, Hennink WE, Storm G. Tumour­targeted nanomedi­
    cines: Principles and practice. British J. Cancer 99 , 392–397 (2008).


49. Owen J, Pankhurst Q, Stride E. Magnetic targeting and ultrasound
    mediated drug delivery: Benefits, limitations and combination. Int. J.
    Hyperthermia 28 (4), 362–373 (2012).


50. Zhang Y, Sun C, Kohler N, Zhang M. Self­assembled coatings on indi­
    vidual monodisperse magnetite nanoparticles for efficient intracellular
    uptake. Biomed. Microdevices 6 , 33–40 (2004).


51. Azarmi S, Roa WH, Löbenberg R. Targeted delivery of nanoparticles for
    the treatment of lung diseases. Adv. Drug Deliv. Rev. 60 , 863–875
    (2008).


52. von Maltzahn G, Park J­H, Lin KY, Singh N, Schwöppe C, Mesters R,
    Berdel WE, Ruoslahti E, Sailor MJ, Bhatia SN. Nanoparticles that com­
    municate in vivo to amplify tumour targeting. Nat. Mater. 10 , 545–552
    (2011).


53. Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer.
    Brit. J. Cancer 96 , 1315–1319 (2007).